Asthma and COVID-19: lessons learned and questions that remain

References

• Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211–1259.
   PubMed Web of Science ®Google Scholar
• Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. Epub 2020/ 04/16. PubMed PMID: 32294485; PubMed Central PMCID: PMCPMC7152876.
   PubMed Web of Science ®Google Scholar
• Rozenfeld Y, Beam J, Maier H, et al. A model of disparities: risk factors associated with COVID-19 infection. Int J Equity Health. 2020;19(1):126. Epub 2020/ 07/31. PubMed PMID: 32727486; PubMed Central PMCID: PMCPMC7387879.
   PubMed Web of Science ®Google Scholar
• Statement on world asthma day 2020 [internet]. National Institutes of Health 2020 Accessed 01 June 2021. Available from: https://www.nih.gov/news-events/news-releases/nih-statement-world-asthma-day-2020
   Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. Epub 2020/ 01/28. PubMed PMID: 31986264; PubMed Central PMCID: PMCPMC7159299.
   PubMed Web of Science ®Google Scholar
• Yu C, Lei Q, Li W, et al. Clinical characteristics, associated factors, and predicting COVID-19 mortality risk: a retrospective study in Wuhan, China. Am J Prev Med. 2020;59(2):168–175. Epub 2020/ 06/23. PubMed PMID: 32564974; PubMed Central PMCID: PMCPMC7250782.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5). Epub 2020/ 03/29. DOI:https://doi.org/10.1183/13993003.00547-2020. PubMed PMID: 32217650; PubMed Central PMCID: PMCPMC7098485.
   Web of Science ®Google Scholar
• Caminati M, Lombardi C, Micheletto C, et al. Asthmatic patients in COVID-19 outbreak: few cases despite many cases. J Allergy Clin Immunol. 2020:S0091-6749(20)30825–3. DOI:https://doi.org/10.1016/j.jaci.2020.05.049. PubMed PMID: 32620309.
   Google Scholar
• Shi L, Xu J, and Xiao W, et al. Asthma in patients with coronavirus disease 2019: a systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2021. DOI:https://doi.org/10.1016/j.anai.2021.02.013. .
   Google Scholar
• Hospitalization surveillance network COVID-NET: centers for disease control and prevention. 2020 Accessed 01 June 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html
   Google Scholar
• Izquierdo JL, Almonacid C, González Y, et al. The impact of COVID-19 on patients with asthma. Eur Respir J. 2020:2003142. DOI:https://doi.org/10.1183/13993003.03142-2020.
   Web of Science ®Google Scholar
• Sdmd A, KLB V, L-pmd B, et al. Overdiagnosis of asthma in obese and nonobese adults: CMAJ CMAJ. Can Med Assoc J. 2008;179(11):1121–1131. PubMed PMID: 205043946; 19015563.
   Web of Science ®Google Scholar
• Chhiba KD, Patel GB, Vu THT, et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol. 2020;146(2):307–14.e4.
   PubMed Web of Science ®Google Scholar
• Mahdavinia M, Foster KJ, Jauregui E, et al. Asthma prolongs intubation in COVID-19. The Journal of Allergy and Clinical Immunology in Practice. 2020;8(7):2388–2391. Epub 2020/ 05/18. PubMed PMID: 32417445; PubMed Central PMCID: PMCPMC7224651.
   PubMed Web of Science ®Google Scholar
• Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763–1770.
   PubMed Web of Science ®Google Scholar
• Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of covid-19 in New York City. N Engl J Med. 2020;382(24):2372–2374.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Hasegawa K, and Ma B, et al. Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 2020;146(2):327–329. e4. e4.
   PubMed Web of Science ®Google Scholar
• Yang JM, Koh HY, and Moon SY, et al. Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study. J Allergy Clin Immunol. 2020. DOI:https://doi.org/10.1016/j.jaci.2020.08.008. *.
   Google Scholar
• Lovinsky-Desir S, Deshpande DR, De A, et al. Asthma among hospitalized patients with COVID-19 and related outcomes. J Allergy Clin Immunol. 2020;146(5):1027–1034. e4. Epub 2020/ 08/11. PubMed PMID: 32771560; PubMed Central PMCID: PMCPMC7409831.
   PubMed Web of Science ®Google Scholar
• Lieberman-Cribbin W, Rapp J, and Alpert N, et al. The impact of asthma on mortality in patients with COVID-19. Chest. 2020. DOI:https://doi.org/10.1016/j.chest.2020.05.575. .
   Google Scholar
• Bloom CI, Drake TM, and Docherty AB, et al. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO clinical characterisation protocol UK. Lancet Respir Med. 2021;9(7):699–711. .
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, and Bhaskaran K, et al. Factors associated with COVID-19-related death using openSAFELY. Nature. 2020;584(7821):430–436. .
   PubMed Web of Science ®Google Scholar
• W-j G, W-h L, Zhao Y, et al. Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis. Eur Respir J. 2020:2000547. DOI:https://doi.org/10.1183/13993003.00547-2020.
   Google Scholar
• Greenberg SB. Respiratory consequences of rhinovirus infection. Arch Internal Med. 2003;163(3):278–284.
   PubMedGoogle Scholar
• Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol. 2010;125(6):1178–1187. quiz 88-9. Epub 2010/ 06/02. PubMed PMID: 20513517; PubMed Central PMCID: PMCPMC7172767.
   PubMed Web of Science ®Google Scholar
• Juhn YJ. Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease? J Allergy Clin Immunol. 2014;134(2):247–259. PubMed PMID: 25087224.
   PubMed Web of Science ®Google Scholar
• Kumar A, Grayson MH. The role of viruses in the development and exacerbation of atopic disease. Ann Allergy Asthma Immunol. 2009;103(3):181–219. PubMed PMID: 19788013.
   PubMed Web of Science ®Google Scholar
• Bønnelykke K, Vissing NH, Sevelsted A, et al. Association between respiratory infections in early life and later asthma is independent of virus type. J Allergy Clin Immunol. 2015;136(1):81–86. e4. Epub 2015/ 04/21. PubMed PMID: 25910716.
   PubMed Web of Science ®Google Scholar
• Liu DX, Liang JQ, Fung TS, et al. Human coronavirus-229E, -OC43, -NL63, and -HKU1. Reference Module in Life Sciences. 2020:B978-0-12-809633-8.21501-X. Epub 2020/ 05/07. DOI: https://doi.org/10.1016/B978-0-12-809633-8.21501-X. PubMed PMID: PMC7204879.
   Google Scholar
• Gern JE.Virus/allergen interaction in asthma exacerbation.Ann Am Thorac Soc.2015;12 Suppl 2(Suppl 2):S137–43. Epub 2015/ 11/26. PubMed PMID: 26595729; PubMed Central PMCID: PMCPMC4722838.
   PubMedGoogle Scholar
• Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 1995;310(6989):1225–1229. PubMed PMID: 7767192.
   PubMed Web of Science ®Google Scholar
• El-Sahly HM, Atmar RL, Glezen WP, et al. Spectrum of clinical illness in hospitalized patients with “common cold” virus infections. Clin Infect Dis. 2000;31(1):96–100. Epub 2000/ 07/17. PubMed PMID: 10913403.
   PubMed Web of Science ®Google Scholar
• Grandbastien M, Piotin A, Godet J, et al. SARS-CoV-2 pneumonia in hospitalized asthmatic patients did not induce severe exacerbation. The Journal of Allergy and Clinical Immunology in Practice. 2020:S2213-198(20)30667-X. DOI:https://doi.org/10.1016/j.jaip.2020.06.032. PubMed PMID: 32603901.
   Google Scholar
• Shah SA, Quint JK, and Nwaru BI, et al. Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data. Thorax. 2021. Epub 2021/ 03/31. DOI: https://doi.org/10.1136/thoraxjnl-2020-216512. Epub 2021/ 03/31. Epub 2021/ 03/31.
   Google Scholar
• Beurnier A, Jutant E-M, and Jevnikar M, et al. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation. Eur Respir J. 2020:2001875. DOI:https://doi.org/10.1183/13993003.01875-2020. .
   Google Scholar
• Konopka KE, Wilson A, Myers JL, et al. Postmortem lung findings in a patient with asthma and coronavirus disease 2019. Chest. 2020. DOI:https://doi.org/10.1016/j.chest.2020.04.032.
   Google Scholar
• Wichmann D, Sperhake J-P, Lütgehetmann M, et al. Autopsy findings and venous thromboembolism in patients with COVID-19 a prospective cohort study. Ann Intern Med. 2020;173(4):268–277. Epub 2020/ 05/06. PubMed PMID: 32374815.
   PubMed Web of Science ®Google Scholar
• Oreskovic NM, Kinane TB, Aryee E, et al. The unexpected risks of COVID-19 on asthma control in children. J Allergy Clin Immunol. 2020. DOI:https://doi.org/10.1016/j.jaip.2020.05.027.
   Google Scholar
• Hartnett KP, Kite-Powell, A, and DeVies J, et al. Impact of the COVID-19 Pandemic on Emergency Department Visits — United States, January 1, 2019–May 30, 2020. Centers for Disease Control and Prevention, 2020.
   Google Scholar
• Kenyon CC, Hill DA, Henrickson SE, et al. Initial effects of the COVID-19 pandemic on pediatric asthma emergency department utilization. J Allergy Clin Immunol. 2020. DOI:https://doi.org/10.1016/j.jaip.2020.05.045.
   Google Scholar
• Birkmeyer J, Barnato A, N. B, et al. The impact of the COVID-19 pandemic on hospital admissions in the United States. Health Affairs. 2020;39(11):2010–2017. *. PubMed PMID: 32970495.
   PubMed Web of Science ®Google Scholar
• Berman JD, Ebisu K. Changes in U.S. air pollution during the COVID-19 pandemic. Sci Total Environ. 2020;739:139864. Epub 2020/ 06/09. PubMed PMID: 32512381; PubMed Central PMCID: PMCPMC7442629.
   PubMed Web of Science ®Google Scholar
• Bashir MF, Ma BJ, and Bilal, et al, Bilal, et al. Correlation between environmental pollution indicators and COVID-19 pandemic: a brief study in Californian context. Environ Res. 2020;187:109652. Epub 2020/ 05/13. Epub 2020/ 05/13.
   PubMed Web of Science ®Google Scholar
• Kaye L, Theye B, Smeenk I, et al. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. The Journal of Allergy and Clinical Immunology in Practice. 2020;8(7):2384–2385. Epub 2020/ 05/01. PubMed PMID: 32371047.
   PubMed Web of Science ®Google Scholar
• Carr TF, Zeki AA, and Kraft M, et al. Eosinophilic and noneosinophilic asthma Am J Respir Crit Care Med . PubMed PMID: 28910134. 2018;197(1):22–37.
   PubMed Web of Science ®Google Scholar
• Kuo CS, Pavlidis S, Loza M, et al. T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED. Eur Respir J. 2017;49(2). DOI:https://doi.org/10.1183/13993003.02135-2016. Epub 2017/ 02/10. PubMed PMID: 28179442.
   Google Scholar
• Lindsley AW, Schwartz JT, Rothenberg ME, et al. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol. 2020;146(1):1–7.
   PubMed Web of Science ®Google Scholar
• Flores-Torres A, Salinas-Carmona M, Salinas E, et al. Eosinophils and respiratory viruses. Viral Immunol. 2019;32(5):198–207. PubMed PMID: 31140942.
   PubMedGoogle Scholar
• Sykes A, Edwards MR, Macintyre J, et al. Rhinovirus 16-induced IFN-α and IFN-β are deficient in bronchoalveolar lavage cells in asthmatic patients. J Allergy Clin Immunol. 2012;129(6):1506–1514. e6 Epub 2012/ 06/05. PubMed PMID: 22657407.
   PubMed Web of Science ®Google Scholar
• Channappanavar R, Fehr AR, Vijay R, et al. dysregulated type i interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 2016;19(2):181–193. Epub 2016/ 02/13. PubMed PMID: 26867177; PubMed Central PMCID: PMCPMC4752723.
   PubMed Web of Science ®Google Scholar
• Ferastraoaru D, Hudes G, Jerschow E, et al. Eosinophilia in asthma patients is protective against severe COVID-19 illness. J Allergy Clin Immunol. 2021;9(3):1152–1162. e3. *.
   Web of Science ®Google Scholar
• Ho KS, Howell D, and Rogers L, et al. The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection. Ann Allergy Asthma Immunol 2021 Jul;127(1):42-48 PMID: 33647451. DOI:https://doi.org/10.1016/j.anai.2021.02.021.
   Google Scholar
• Sungnak W, Huang N, Bécavin C, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681–687.
   PubMed Web of Science ®Google Scholar
• Polverino F. Cigarette smoking and COVID-19: a complex interaction. Am J Respir Crit Care Med. 2020;202(3):471–472. PubMed PMID: 32530714.
   PubMed Web of Science ®Google Scholar
• Health NYSDo. COVID-19 tracker: fatalities 2020. [2020 9 10]. Available from: https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-Fatalities?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
   Google Scholar
• Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146(1):203–206. e3. Epub 2020/ 04/22. PubMed PMID: 32333915.
   PubMed Web of Science ®Google Scholar
• Matusiak M, Schürch CM.Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics.Respir Res.2020;21(1):252. Epub 2020/ 10/01. PubMed PMID: 32993656; PubMed Central PMCID: PMCPMC7523260.
   PubMed Web of Science ®Google Scholar
• Sajuthi SP, DeFord P, Li Y, et al. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium. Nat Commun. 2020;11(1):5139. Epub 2020/ 10/14. PubMed PMID: 33046696; PubMed Central PMCID: PMCPMC7550582.
   PubMed Web of Science ®Google Scholar
• Bunyavanich S, Do A, Vicencio A, et al. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. Jama. 2020;323(23):2427–2429. Epub 2020/ 05/21. PubMed PMID: 32432657; PubMed Central PMCID: PMCPMC7240631 Biosolutions. No other disclosures were reported.
   PubMed Web of Science ®Google Scholar
• Ng KW, Attig J, Bolland W, et al. Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option. Nat Genet. 2020;52(12):1294–1302.
   PubMed Web of Science ®Google Scholar
• Onabajo OO, Banday AR, Stanifer ML, et al. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Nat Genet. 2020;52(12):1283–1293.
   PubMed Web of Science ®Google Scholar
• Blume C, Jackson CL, Spalluto CM, et al. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection. Nat Genet. 2021;53(2):205–214.
   PubMed Web of Science ®Google Scholar
• Bradding P, Richardson M, TSC H, et al. ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma—implications for COVID-19. J Allergy Clin Immunol. 2020;146(1):208–211.
   PubMed Web of Science ®Google Scholar
• Peters MC, Sajuthi S, Deford P, et al. COVID-19–related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids. Am J Respir Crit Care Med. 2020;202(1):83–90. PubMed PMID: 32348692.
   PubMed Web of Science ®Google Scholar
• Radzikowska U, Ding M, Tan G, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020;75(11):2829–2845. Epub 2020/ 06/05. PubMed PMID: 32496587; PubMed Central PMCID: PMCPMC7300910.
   PubMed Web of Science ®Google Scholar
• Kimura H, Francisco D, Conway M, et al. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. J Allergy Clin Immunol. 2020;146(1):80–88. e8.
   PubMed Web of Science ®Google Scholar
• Sajuthi SP, DeFord P, Jackson ND, et al. Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium. bioRxiv. 2020:2020.04.09.034454. DOI:https://doi.org/10.1101/2020.04.09.034454. PubMed PMID: 32511326.
   Google Scholar
• Saheb Sharif-Askari N, Saheb Sharif-Askari F, Alabed M, et al. Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD. Mol Ther Methods Clin Dev. 2020;18:1–6.
   PubMed Web of Science ®Google Scholar
• Kermani NZ, Song W-J, Badi Y, et al. Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma. Respir Res. 2021;22(1):10.
   PubMed Web of Science ®Google Scholar
• Global Strategy for Asthma Management and Prevention, 2020. Global Initiative for Asthma (Fontana, WI 53125, USA: Global Initiative for Asthma). 2020.
   Google Scholar
• Oliver BGG, Robinson P, Peters M, et al. Viral infections and asthma: an inflammatory interface? Eur Respir J. 2014;44(6):1666–1681.
   PubMed Web of Science ®Google Scholar
• Sabroe I, Postma D, Heijink I, et al. The yin and the yang of immunosuppression with inhaled corticosteroids. Thorax. 2013;68(12):1085–1087. Epub 2013/ 08/10. PubMed PMID: 23929790.
   PubMed Web of Science ®Google Scholar
• Davies JM, Carroll ML, Li H, et al. Budesonide and formoterol reduce early innate anti-viral immune responses in vitro. PloS One. 2011;6(11):e27898.
   PubMed Web of Science ®Google Scholar
• Singanayagam A, Glanville N, Girkin JL, et al. Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations. Nat Commun. 2018;9(1):2229. PubMed PMID: 29884817.
   PubMed Web of Science ®Google Scholar
• Yamaya M, Nishimura H, Deng X, et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig. 2020;58(3):155–168. Epub 2020/ 02/26. PubMed PMID: 32094077; PubMed Central PMCID: PMCPMC7102607.
   PubMed Web of Science ®Google Scholar
• Bochkov YA, Busse WW, Brockman-Schneider RA, et al. Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses. Respir Res. 2013;14(1):98. Epub 2013/ 11/14. PubMed PMID: 24219422; PubMed Central PMCID: PMCPMC3851834.
   PubMedGoogle Scholar
• Simpson JL, Carroll M, Yang IA, et al. Reduced antiviral interferon production in poorly controlled asthma is associated with neutrophilic inflammation and high-dose inhaled corticosteroids. Chest. 2016;149(3):704–713. Epub 2016/ 02/03. PubMed PMID: 26836898.
   PubMed Web of Science ®Google Scholar
• Artigas A, Camprubí-Rimblas M, Tantinyà N, et al. Inhalation therapies in acute respiratory distress syndrome. Ann Transl Med. 2017;5(14):293. Epub 2017/ 08/23. PubMed PMID: 28828368; PubMed Central PMCID: PMCPMC5537120.
   PubMed Web of Science ®Google Scholar
• Matsuyama S, Kawase M, and Nao N, et al. The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells. J Virol. 2020;95(1). Epub 2020/ 10/16. DOI: https://doi.org/10.1128/jvi.01648-20. Epub 2020/ 10/16. Epub 2020/ 10/16.
   Google Scholar
• Schultze A, Walker AJ, and MacKenna B, et al. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the openSAFELY platform. Lancet Respir Med 2021 Nov;8(11):1106-1120 . DOI:https://doi.org/10.1016/S2213-2600(20)30415-X.
   Google Scholar
• Wang L, Foer D, Bates DW, et al. Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19. J Allergy Clin Immunol. 2020;146(4):808–812. Epub 2020/ 08/01. PubMed PMID: 32735807; PubMed Central PMCID: PMCPMC7387277.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan S, Nicolau DV Jr., and Langford B, et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med 2021 Jul;9(7):763-772 . *. DOI:https://doi.org/10.1016/S2213-2600(21)00160-0.
   Google Scholar
• Jackson DJ, Trujillo-Torralbo MB, Del-rosario J, et al. The influence of asthma control on the severity of virus-induced asthma exacerbations. J Allergy Clin Immunol. 2015;136(2):497–500. e3. Epub 2015/ 03/17. PubMed PMID: 25772596.
   PubMed Web of Science ®Google Scholar
• Schad C, Gentile DA, Patel A, et al. Effect of montelukast on pro-inflammatory cytokine production during naturally acquired viral upper respiratory infections (vURIs) in adults. J Allergy Clin Immunol. 2008;121(2):S74.
   Web of Science ®Google Scholar
• Halpin DMG, Singh D, Hadfield RM, et al. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020;55(5). DOI:https://doi.org/10.1183/13993003.01009-2020. Epub 2020/ 04/29. PubMed PMID: 32341100; PubMed Central PMCID: PMCPMC7236828.
   Google Scholar
• Akenroye AT, Wood R, Keet C, et al. Asthma, biologics, corticosteroids, and coronavirus disease 2019. Ann Allergy Asthma Immunol. 2020;125(1):12–13. Epub 2020/ 05/11. PubMed PMID: 32387535; PubMed Central PMCID: PMCPMC7202805.
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):1–11. PubMed PMID: 32167524.
   Web of Science ®Google Scholar
• Yuan M, Xu X, Xia D, et al. Effects of corticosteroid treatment for non-severe COVID-19 pneumonia: a propensity score-based analysis. Shock. 2020. Epub 2020/ 06/05. DOI: https://doi.org/10.1097/shk.0000000000001574. PubMed PMID: 32496422.
   Google Scholar
• Horby PLW, Emberson J, Mafham M, et al. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2020;384(8):693–704.
   PubMed Web of Science ®Google Scholar
• Bhalla A, Mukherjee M, and Radford K, et al. Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology. Allergy 2021 . n/a(n/a Mar;76(3):957-958). DOI:https://doi.org/10.1111/all.14534.
   Google Scholar
• Esquivel A, Busse WW, Calatroni A, et al. Effects of omalizumab on rhinovirus infections, illnesses, and exacerbations of asthma. Am J Respir Crit Care Med. 2017;196(8):985–992. PubMed PMID: 28608756.
   PubMed Web of Science ®Google Scholar
• Durrani SR, Montville DJ, Pratt AS, et al. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol. 2012;130(2):489–495.
   PubMed Web of Science ®Google Scholar
• Teach SJ, Gill MA, Togias A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015;136(6):1476–1485. Epub 2015/ 11/01. PubMed PMID: 26518090; PubMed Central PMCID: PMCPMC4679705.
   PubMed Web of Science ®Google Scholar
• Morais-Almeida M, Aguiar R, Martin B, et al. COVID-19, asthma, and biological therapies: what we need to know. World Allergy Organ J. 2020;13(5):100126. *. PubMed PMID: 32426090.
   PubMed Web of Science ®Google Scholar
• Auffray C, Adcock IM, Chung KF, et al. An integrative systems biology approach to understanding pulmonary diseases. Chest. 2010;137(6):1410–1416. Epub 2010/ 06/09. PubMed PMID: 20525651.
   PubMed Web of Science ®Google Scholar
• Wenzel SE, Busse WW. Severe asthma: lessons from the severe asthma research program. J Allergy Clin Immunol. 2007;119(1):14–21. quiz 2-3. Epub 2007/ 01/09. PubMed PMID: 17208583.
   PubMed Web of Science ®Google Scholar
• Silkoff PE, Strambu I, Laviolette M, et al. Asthma characteristics and biomarkers from the airways disease endotyping for personalized therapeutics (ADEPT) longitudinal profiling study. Respir Res. 2015;16(1):142.
   PubMedGoogle Scholar